Digest Network Come funziona
Network
/
Società
In
Non verificato

Innoviva Specialty Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaHIV, AIDS e malattie autoimmuniIndustriaSalute

4 comunicati stampa

Guarda tutti i comunicati
13/08/2025
Biotecnologia
Salute
Scienza
Farmaceutica
Eventi
Industria
Innoviva Specialty Therapeutics’ Antimicrobial Therapies ZEVTERA® and XACDURO® Nominated for the 2025 Prix Galien USA Best Pharmaceutical Product Award
Fonte
Innoviva Specialty Therapeutics, Inc.
Emittente
Business Wire
1.00
0
12/06/2025
Igiene alimentare
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025
Fonte
Innoviva Specialty Therapeutics, Inc.
Emittente
Business Wire
1.00
0
20/05/2025
Industria
Igiene alimentare
Salute
HIV, AIDS e malattie autoimmuni
Sanità
Farmaceutica
Biotecnologia
ZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial Infections
Fonte
Innoviva Specialty Therapeutics, Inc.
Emittente
Business Wire
1.00
0
15/10/2024
Eventi
Fiere
Industria
Scienza
HIV, AIDS e malattie autoimmuni
Sanità
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Innoviva Specialty Therapeutics to Present New Clinical Data From Its Development Pipeline and Broad Commercial Portfolio at IDWeek 2024
Fonte
Innoviva Specialty Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0